Impax Asset Management Group »

Crinetics Pharmaceuticals In shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 275k 46.55

More positions owned by Impax Asset Management Group

Linde Common Stock (LIN)
Microsoft Corp Common Stock (MSFT)
Xylem Common Stock (XYL)
NVIDIA Corp Common Stock (NVDA)
Hubbell Common Stock (HUBB)
Agilent Technologies Common Stock (A)
Pentair Common Stock (PNR)
Aptiv Common Stock (APTV)
Veralto Corp Common Stock (VLTO)
American Water Works Common Stock (AWK)
A O Smith Corp Common Stock (AOS)
IDEX Corp Common Stock (IEX)
Advanced Drainage Systems Common Stock (WMS)
eBay Common Stock (EBAY)
RenaissanceRe Holdings Common Stock (RNR)

View all positions for Impax Asset Management Group

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Farallon Capital Management
Driehaus Capital Management
EcoR1 Capital
Henderson Group
Point72 Asset Management
Geode Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Pictet Asset Management Holding SA
Siren

View all funds holding Crinetics Pharmaceuticals In